View all cases
UPC CFI 505/2023
Jan 10, 2024·EP3536712: METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
- Case details
- StatusCase ClosedActionInfringementCategoryMain Infringement Action
- Parties
- Division
- Dusseldorf LD
- Technology
- Biotech · Antibody · Organic Chemistry
- Language
- English
Documents
| Document title | Date | Public |
|---|---|---|
| Cover sheet | 2025-11-03 | Not public |
| Application document Defendant | 2025-11-03 | Not public |
| Receipt | 2025-11-03 | Not public |
| Receipt | 2025-06-27 | Not public |
| 250623 Request re. Audio Recording | 2025-06-23 | Not public |
| Outcome of the Order | 2025-06-16 | Not public |
| Workflow closed | 2025-06-16 | Public |
| Receipt | 2025-06-13 | Not public |
| 20250613_Application_cost_decision_Amgen | 2025-06-13 | Not public |
| Headnote-and-Keywords | 2025-05-13 | Not public |
| DecisionOutcome | 2025-05-13 | Not public |
| Final decision | 2025-05-13 | Public |
| Outcome of the Order | 2025-04-30 | Not public |
| Confirmation of appointment | 2025-04-30 | Public |
| Receipt | 2025-04-22 | Not public |
| 20250417_Recording_of_oral_hearing_Request_Amgen_en | 2025-04-17 | Not public |
| Reschedule announcement | 2025-04-04 | Public |
| Receipt | 2025-03-03 | Not public |
| 250227 Email re correction | 2025-03-03 | Not public |
| 250214 Order Correction of Claimant's name | 2025-03-03 | Not public |
| Request for correction | 2025-03-03 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S03 | 2025-02-26 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S03 | 2025-02-26 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S04 | 2025-02-26 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S01 | 2025-02-26 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S02 | 2025-02-26 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S02 | 2025-02-26 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S04 | 2025-02-26 | Not public |
| 597355/2023/OH/DUS-LOC/UPC202502250930AM/S01 | 2025-02-26 | Not public |
| Interim-Procedure-Closure | 2025-02-21 | Not public |
| Summon-Oral-Hearing | 2025-02-21 | Not public |
| New upload due to technical reasons | 2025-02-21 | Public |
| Hearing-Dates | 2025-02-21 | Not public |
| Response on requests and synoptical table | 2025-02-21 | Not public |
| Summary of citations | 2025-02-21 | Not public |
| Exhibit BP 85 - Amgen | 2025-02-21 | Not public |
| 20250221_Table_of_Exhibits_and_Request_ARs_Brief_Amgen | 2025-02-21 | Not public |
| Course of the oral hearing | 2025-02-20 | Public |
| Outcome of the Order | 2025-02-20 | Not public |
| Rejecting Time Extension | 2025-02-20 | Public |
| Rectification Order 2025_02_03 | 2025-02-20 | Not public |
| Order Interim Procedure | 2025-02-19 | Public |
| Template-Order | 2025-02-19 | Not public |
| Written-Procedure-Closure | 2025-02-19 | Not public |
| Outcome of the Order | 2025-02-19 | Not public |
| Art. 33 3)(a) UPCA | 2025-02-19 | Public |
| Receipt | 2025-02-19 | Not public |
| Cover letter on submssion of slides | 2025-02-18 | Not public |
| Slides for the hearing on 25 February 2025 | 2025-02-18 | Not public |
| Request on timing of complete statement of claim | 2025-02-18 | Not public |
| 20250218_Comment_re_CfR_Amgen_App_5925_2025_en_signed | 2025-02-18 | Not public |
| 20250218_Comment_re_CfR_Amgen_App_5925_2025_en_signed | 2025-02-18 | Not public |
| 20250218_Comment_re_CfR_Amgen_App_5925_2025_en_signed | 2025-02-18 | Not public |
| 20250218_Comment_re_CfR_Amgen_App_5925_2025_en_signed | 2025-02-18 | Not public |
| 20250218_Comment_re_CfR_Amgen_App_5925_2025_en_signed | 2025-02-18 | Not public |
| 20250218_Comment_re_CfR_Amgen_App_5925_2025_en_signed | 2025-02-18 | Not public |
| 20250218_Comment_re_CfR_Amgen_App_5925_2025_en_signed | 2025-02-18 | Not public |
| Receipt | 2025-02-18 | Not public |
| Exhibit_BP84_Amgen | 2025-02-18 | Not public |
| 20250218_Response_Amgen_App_6226_2025 | 2025-02-18 | Not public |
| Outcome of the Order | 2025-02-14 | Not public |
| Decision regarding R.9 request | 2025-02-14 | Public |
| Opportunity to comment | 2025-02-14 | Not public |
| Outcome of the Order | 2025-02-14 | Not public |
| Correction Name | 2025-02-14 | Public |
| Receipt | 2025-02-06 | Not public |
| 3rd Prof. Parhofer declaration | 2025-02-05 | Not public |
| HE 116a | 2025-02-05 | Not public |
| HE 116a | 2025-02-05 | Not public |
| Application pursuant to Rule 9.1 RoP | 2025-02-05 | Not public |
| Receipt | 2025-02-05 | Not public |
| Sanofi v Amgen - Rule 336 RoP - Request to file demonstratives | 2025-02-04 | Not public |
| Rectification | 2025-02-03 | Public |
| Rectification | 2025-02-03 | Public |
| Separation of proceedings | 2025-01-30 | Public |
| Receipt | 2025-01-21 | Not public |
| 250120 Reply to Order on separation and value of action | 2025-01-20 | Not public |
| Receipt | 2025-01-20 | Not public |
| Response_re_separation_of_EP857_and_value_in_litigation | 2025-01-20 | Not public |
| Preliminary_Objection_DecisionOutcome | 2024-12-23 | Not public |
| R. 20.2 RoP Information | 2024-12-23 | Public |
| Hearing-Dates | 2024-12-13 | Not public |
| Order - set date and summon to oral hearing | 2024-12-13 | Public |
| Hearing-Dates | 2024-12-13 | Not public |
| Panel-Appointment | 2024-12-05 | Not public |
| Outcome of the Order | 2024-11-29 | Not public |
| Order Inform PCFI allocation TQJ | 2024-11-29 | Public |
| Receipt | 2024-11-14 | Not public |
| Exhibit BP82_Minutes oral hearing in main damages case | 2024-11-13 | Not public |
| Exhibit BP83_court notice re re-scheduled oral hearing in main damages case | 2024-11-13 | Not public |
| Application to comment re. scheduling - Nov 13 2024 | 2024-11-13 | Not public |
| HE 115 241016 Munich Court order | 2024-11-11 | Not public |
| 241111 Comments | 2024-11-11 | Not public |
| HE 114 Confirmation Ski Rauline (redacted) | 2024-11-11 | Not public |
| HE 115 241016 Munich Court order | 2024-11-11 | Not public |
| HE 114 Confirmation Ski Rauline (redacted) | 2024-11-11 | Not public |
| 241111 Comments | 2024-11-11 | Not public |
| 20241111_Request_for_hearing_date_Brief_of_Amgen | 2024-11-11 | Not public |
| 20241111_Request_for_hearing_date_Brief_of_Amgen | 2024-11-11 | Not public |
| 20241111_Request_for_hearing_date_Brief_of_Amgen | 2024-11-11 | Not public |
| 20241111_Request_for_hearing_date_Brief_of_Amgen | 2024-11-11 | Not public |
| 20241111_Request_for_hearing_date_Brief_of_Amgen | 2024-11-11 | Not public |
| 20241111_Request_for_hearing_date_Brief_of_Amgen | 2024-11-11 | Not public |
| 20241111_Request_for_hearing_date_Brief_of_Amgen | 2024-11-11 | Not public |
| Pre-Order Opportunity to comment Oral hearing date | 2024-11-05 | Not public |
| Receipt | 2024-10-21 | Not public |
| EP857 Reply to Amgen response to application for leave to amend case (signed) | 2024-10-18 | Not public |
| Response to application for leave to amend the case R263 | 2024-10-09 | Not public |
| Response to application for leave to amend the case R263 | 2024-10-09 | Not public |
| Response to application for leave to amend the case R263 | 2024-10-09 | Not public |
| Response to application for leave to amend the case R263 | 2024-10-09 | Not public |
| Response to application for leave to amend the case R263 | 2024-10-09 | Not public |
| Response to application for leave to amend the case R263 | 2024-10-09 | Not public |
| Response to application for leave to amend the case R263 | 2024-10-09 | Not public |
| Receipt | 2024-10-09 | Not public |
| 241008 Submission on lis pendens | 2024-10-08 | Not public |
| Receipt | 2024-10-04 | Not public |
| Correction | 2024-10-04 | Not public |
| Receipt | 2024-10-04 | Not public |
| Application | 2024-10-03 | Not public |
| Order Opportunity to comment | 2024-09-26 | Not public |
| Receipt | 2024-09-25 | Not public |
| Exhibit HE 106 | 2024-09-25 | Not public |
| HE 104 Decision to grant | 2024-09-25 | Not public |
| Exhibit HE 108 | 2024-09-25 | Not public |
| HE 107 Confirmatory License Agreement | 2024-09-25 | Not public |
| HE 105 Intention to grant | 2024-09-25 | Not public |
| Exhibit HE 109 | 2024-09-25 | Not public |
| Application to Amend Case | 2024-09-25 | Not public |
| Acknowledgement-of-lodging | 2024-09-23 | Not public |
| Acknowledgement-of-lodging | 2024-09-23 | Not public |
| Acknowledgement-of-lodging | 2024-09-23 | Not public |
| Acknowledgement-of-lodging | 2024-09-23 | Not public |
| Acknowledgement-of-lodging | 2024-09-23 | Not public |
| Acknowledgement-of-lodging | 2024-09-23 | Not public |
| Acknowledgement-of-lodging | 2024-09-23 | Not public |
| Exhibit_BP77 | 2024-09-23 | Not public |
| Exhibit_BP78 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP80 | 2024-09-23 | Not public |
| Exhibit_BP79 | 2024-09-23 | Not public |
| Exhibit_BP81 | 2024-09-23 | Not public |
| Exhibit_BP76 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Infringement rejoinder and validity reply | 2024-09-23 | Not public |
| Exhibit_BP78 | 2024-09-23 | Not public |
| Infringement rejoinder and validity reply | 2024-09-23 | Not public |
| Exhibit_BP79 | 2024-09-23 | Not public |
| Exhibit_BP77 | 2024-09-23 | Not public |
| Exhibit_BP81 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP80 | 2024-09-23 | Not public |
| Exhibit_BP76 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Infringement rejoinder and validity reply | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP78 | 2024-09-23 | Not public |
| Exhibit_BP80 | 2024-09-23 | Not public |
| Exhibit_BP76 | 2024-09-23 | Not public |
| Exhibit_BP79 | 2024-09-23 | Not public |
| Exhibit_BP77 | 2024-09-23 | Not public |
| Exhibit_BP81 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP77 | 2024-09-23 | Not public |
| Exhibit_BP76 | 2024-09-23 | Not public |
| Exhibit_BP79 | 2024-09-23 | Not public |
| Exhibit_BP80 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP81 | 2024-09-23 | Not public |
| Exhibit_BP78 | 2024-09-23 | Not public |
| Infringement rejoinder and validity reply | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP81 | 2024-09-23 | Not public |
| Exhibit_BP76 | 2024-09-23 | Not public |
| Exhibit_BP78 | 2024-09-23 | Not public |
| Exhibit_BP77 | 2024-09-23 | Not public |
| Exhibit_BP80 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP79 | 2024-09-23 | Not public |
| Infringement rejoinder and validity reply | 2024-09-23 | Not public |
| Exhibit_BP76 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP81 | 2024-09-23 | Not public |
| Exhibit_BP80 | 2024-09-23 | Not public |
| Exhibit_BP77 | 2024-09-23 | Not public |
| Exhibit_BP79 | 2024-09-23 | Not public |
| Exhibit_BP78 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Infringement rejoinder and validity reply | 2024-09-23 | Not public |
| Exhibit_BP78 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP77 | 2024-09-23 | Not public |
| Exhibit_BP80 | 2024-09-23 | Not public |
| Exhibit_BP75 | 2024-09-23 | Not public |
| Exhibit_BP76 | 2024-09-23 | Not public |
| Infringement rejoinder and validity reply | 2024-09-23 | Not public |
| Exhibit_BP81 | 2024-09-23 | Not public |
| Exhibit_BP79 | 2024-09-23 | Not public |
| Acknowledgement-of-lodging | 2024-07-22 | Not public |
| Reply to defence and defence to counterclaim | 2024-07-22 | Not public |
| Acknowledgement-of-lodging | 2024-07-22 | Not public |
| Reply to defence and defence to counterclaim | 2024-07-22 | Not public |
| Acknowledgement-of-lodging | 2024-07-22 | Not public |
| Reply to defence and defence to counterclaim | 2024-07-22 | Not public |
| Acknowledgement-of-lodging | 2024-07-22 | Not public |
| Reply to defence and defence to counterclaim | 2024-07-22 | Not public |
| Acknowledgement-of-lodging | 2024-07-22 | Not public |
| Reply to defence and defence to counterclaim | 2024-07-22 | Not public |
| Acknowledgement-of-lodging | 2024-07-22 | Not public |
| Reply to defence and defence to counterclaim | 2024-07-22 | Not public |
| Acknowledgement-of-lodging | 2024-07-22 | Not public |
| AR 2 - clean | 2024-07-22 | Not public |
| HE 54 - Form 8-K filing to US SEC April 7 2020 | 2024-07-22 | Not public |
| HE 45 - Amgens reply of 25 April 2024 | 2024-07-22 | Not public |
| HE 74 - Soutar 1991 | 2024-07-22 | Not public |
| HE 59 - Bonny eingetreten im November 2019 - Sanofi Biotechnology SAS (FR) | 2024-07-22 | Not public |
| HE 58 - Confirmation of Power to Act - July 16 2024 | 2024-07-22 | Not public |
| HE 49 - SmPC training presentation of the EMAs SmPC Advisory group | 2024-07-22 | Not public |
| HE 60 - Lippi 2011 | 2024-07-22 | Not public |
| HE 67 - Kochinsky and Marcovina 2009 | 2024-07-22 | Not public |
| HE 99 - Szarek 2020 | 2024-07-22 | Not public |
| HE 80 - Schwartz 2018 | 2024-07-22 | Not public |
| HE 101 SmPC for Repatha (2015) | 2024-07-22 | Not public |
| HE 62 - Tregouet 2009 | 2024-07-22 | Not public |
| HE 83 - Albers 2013 (AIM-HIGH) | 2024-07-22 | Not public |
| HE 57a - EN | 2024-07-22 | Not public |
| HE 78 - Cohen 2006 | 2024-07-22 | Not public |
| HE 57 - Laurent Gilhodes as chairman of Sanofi Biotechnologies SAS (FR) | 2024-07-22 | Not public |
| HE 97 Declaration of Prof Di Angelantonio | 2024-07-22 | Not public |
| AR 5a - tracked | 2024-07-22 | Not public |
| AR 5 - clean | 2024-07-22 | Not public |
| HE 75 - Schmidt 2016 | 2024-07-22 | Not public |
| HE 45a - EN | 2024-07-22 | Not public |
| HE 46a - O Donoghue et al supplemental material | 2024-07-22 | Not public |
| AR 1 - clean | 2024-07-22 | Not public |
| HE 50 - Statement of defence (DE) | 2024-07-22 | Not public |
| HE 85 - Romangnuolo 2015 | 2024-07-22 | Not public |
| AR 1a - tracked | 2024-07-22 | Not public |
| HE 47a - EN | 2024-07-22 | Not public |
| HE 46 - O Donoghue et al circulation | 2024-07-22 | Not public |
| HE 40b - Verification of electronic signatures for HE 40 | 2024-07-22 | Not public |
| HE 51a - Report from the CMDh meeting held on 16th 17th and 18th January 2012 | 2024-07-22 | Not public |
| HE 68 - Koschinsky and Boffa 2014 | 2024-07-22 | Not public |
| HE 52 -SmPC Atorvastatin (DE) | 2024-07-22 | Not public |
| AR 3 - clean | 2024-07-22 | Not public |
| HE 61 - Davignon 2010 | 2024-07-22 | Not public |
| HE 89 - Praluent FDA approval | 2024-07-22 | Not public |
| HE 48 - C Ronse | 2024-07-22 | Not public |
| HE 98 - Safarova 2013 | 2024-07-22 | Not public |
| AR 1b - amended description | 2024-07-22 | Not public |
| HE 93 - Excerpt from clinicaltrials gov - GAUSS | 2024-07-22 | Not public |
| HE 72 - Anuurad 2006 | 2024-07-22 | Not public |
| AR 3a - tracked | 2024-07-22 | Not public |
| HE 82 - Willeit 2018 | 2024-07-22 | Not public |
| HE 77 - Colhoun 2003 | 2024-07-22 | Not public |
| HE 91 - NCT012884443 2011 | 2024-07-22 | Not public |
| HE 51 - CHMP 2012 | 2024-07-22 | Not public |
| HE 73 - Lamon Fava 2014 | 2024-07-22 | Not public |
| HE 81 - Sabatine 2017 | 2024-07-22 | Not public |
| HE 76 - Lambert 2017 | 2024-07-22 | Not public |
| HE 69 - Kolski 2012 | 2024-07-22 | Not public |
| HE 64 - Clarke 2009 | 2024-07-22 | Not public |
| HE 38a - Verification of electronic signatures for HE 38 | 2024-07-22 | Not public |
| HE 95 - Lagor and Millar 2009 | 2024-07-22 | Not public |
| HE 47 - Paris 20 Ocober 2023 1913662 (FR) | 2024-07-22 | Not public |
| HE 55 - PoA executed by Gilhodes (FR) | 2024-07-22 | Not public |
| HE 71 - Rader 1995 | 2024-07-22 | Not public |
| HE 103 - Stein 2009 | 2024-07-22 | Not public |
| HE 53 - 2nd Parhofer declaration Infringment | 2024-07-22 | Not public |
| HE 100 - Summary of pre-priority clinical trials using anti-PCSK9 antibodies | 2024-07-22 | Not public |
| AR 2a - tracked | 2024-07-22 | Not public |
| HE 63 - Kamstrup 2009 | 2024-07-22 | Not public |
| AR 3b - amended description | 2024-07-22 | Not public |
| HE 96 - Swergold poster | 2024-07-22 | Not public |
| HE 94 - Excerpt from clinicaltrials gov - AMG145 | 2024-07-22 | Not public |
| HE 58a - Coury Witness Statement 18 July 2024 | 2024-07-22 | Not public |
| HE 88 - Kamstrup 2008 | 2024-07-22 | Not public |
| AR 4b - amended description | 2024-07-22 | Not public |
| HE 86 - Cohen 2005 | 2024-07-22 | Not public |
| HE 84 - Stroes 2016 | 2024-07-22 | Not public |
| HE 87 - JAMA 2009 | 2024-07-22 | Not public |
| HE 92 Declaration of Prof Parhofer on validity | 2024-07-22 | Not public |
| HE 65 - Dube 2012 | 2024-07-22 | Not public |
| HE 90 - Repatha FDA approval | 2024-07-22 | Not public |
| HE 66 - Jacobson 2013 | 2024-07-22 | Not public |
| AR 4a - tracked | 2024-07-22 | Not public |
| AR 2b - amended description | 2024-07-22 | Not public |
| HE 56 - Second Confirmatory License Agreement | 2024-07-22 | Not public |
| HE 102 - SmPC for Praluent (2015) | 2024-07-22 | Not public |
| Reply to Defence and Defence to Counterclaim | 2024-07-22 | Not public |
| HE 70 - Hobbs 1999 | 2024-07-22 | Not public |
| HE 55a - EN | 2024-07-22 | Not public |
| AR 4 - clean | 2024-07-22 | Not public |
| HE 50a - EN | 2024-07-22 | Not public |
| HE 79 - Ober 2009 | 2024-07-22 | Not public |
| HE 59a - EN | 2024-07-22 | Not public |
| AR 5b - amended description | 2024-07-22 | Not public |
| Outcome of the Order | 2024-07-01 | Not public |
| 2024-07-01 Procedural Order Extension time limit | 2024-07-01 | Public |
| Response_on_time_extension_request_from_Sanofi | 2024-07-01 | Not public |
| Opportunity to comment | 2024-06-26 | Not public |
| Receipt | 2024-06-26 | Not public |
| 2024.06.25 - Request for an extension | 2024-06-25 | Not public |
| Exhibit_BP74 | 2024-06-20 | Not public |
| Fruther_brief_re_preliminary_objection_EN | 2024-06-20 | Not public |
| 240517 Notice re preliminary objection_sgn | 2024-06-18 | Not public |
| HE 43a - Translation HE 43 | 2024-06-18 | Not public |
| HE 44a - Translation HE 44 | 2024-06-18 | Not public |
| HE 43 - RC Dusseldorf Order of 13 May 2024 | 2024-06-18 | Not public |
| HE 44 - RC Dusseldorf Order of 3 May 2024 | 2024-06-18 | Not public |
| Case Management Preliminary Objection | 2024-06-17 | Not public |
| Receipt | 2024-05-21 | Not public |
| Request to Produce Evidence | 2024-05-21 | Not public |
| Request to Produce Evidence | 2024-05-21 | Not public |
| Request to Produce Evidence | 2024-05-21 | Not public |
| Receipt | 2024-05-17 | Not public |
| HE 44 | 2024-05-17 | Not public |
| HE 43a | 2024-05-17 | Not public |
| HE 44a | 2024-05-17 | Not public |
| Notice re PO | 2024-05-17 | Not public |
| HE 43 | 2024-05-17 | Not public |
| Notice re PO | 2024-05-17 | Not public |
| HE 44 | 2024-05-17 | Not public |
| HE 43a | 2024-05-17 | Not public |
| HE 44a | 2024-05-17 | Not public |
| HE 43 | 2024-05-17 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-05-06 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-05-06 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-05-06 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-05-06 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-05-06 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-05-06 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-05-06 | Not public |
| Acknowledgement-of-lodging | 2024-05-03 | Not public |
| Acknowledgement-of-lodging | 2024-05-03 | Not public |
| Exhibit_BP63a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP24_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP20_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP33_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP70a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP57_Amgen_en | 2024-05-03 | Not public |
| Statement_of_defense_and_Counterclaim_for_Revocation_Amgen_May_3_2024_en signed | 2024-05-03 | Not public |
| Exhibit_BP34a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_2_en | 2024-05-03 | Not public |
| Exhibit_BP37_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP22_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP43_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP42_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP55_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68a-Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_3_en | 2024-05-03 | Not public |
| Exhibit_BP45_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP15_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP36_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP13_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP65_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP18_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP16_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP69a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP33a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP39_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP58_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP10_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP66_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP11_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP69_Amgen_be | 2024-05-03 | Not public |
| Exhibit_BP66a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP72_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP71_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP12_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP31_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP17_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP08_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP05_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP48_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP46a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP30_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP14_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP44_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP25_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP63_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP53a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP28_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_4_en | 2024-05-03 | Not public |
| Exhibit_BP29_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP59_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP19_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP09_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP35_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP27_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_1_en | 2024-05-03 | Not public |
| Exhibit_BP62_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP34_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP23_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_1_fr | 2024-05-03 | Not public |
| Exhibit_BP49a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP32_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP40_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP41_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP21_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_2_fr | 2024-05-03 | Not public |
| Exhibit_BP73_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP67_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP52_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP38_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP61_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP26_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP54_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP07_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP33_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_1_fr | 2024-05-03 | Not public |
| Exhibit_BP71_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP35_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP29_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP39_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP13_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP41_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP54_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP07_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP18_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP09_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP26_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP62_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP57_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP34a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_1_en | 2024-05-03 | Not public |
| Exhibit_BP66_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP21_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP63_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP70_Amgen_de | 2024-05-03 | Not public |
| Statement_of_defense_and_Counterclaim_for_Revocation_Amgen_May_3_2024_en signed | 2024-05-03 | Not public |
| Exhibit_BP73_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP58_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP27_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP45_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP24_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP19_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP43_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP16_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP15_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP38_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP59_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP25_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP42_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68a-Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP34_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP69_Amgen_be | 2024-05-03 | Not public |
| Exhibit_BP20_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP36_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP33a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_2_en | 2024-05-03 | Not public |
| Exhibit_BP63a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP14_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP28_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP23_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP17_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_4_en | 2024-05-03 | Not public |
| Exhibit_BP56a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP37_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_2_fr | 2024-05-03 | Not public |
| Exhibit_BP69a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP10_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP31_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP11_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP08_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP55_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP30_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP72_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP61_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP05_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_3_en | 2024-05-03 | Not public |
| Exhibit_BP44_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP12_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP47_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP60_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP68_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP46a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP40_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP65_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP22_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP32_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP66a_Amgen_en | 2024-05-03 | Not public |
| Acknowledgement-of-lodging | 2024-05-03 | Not public |
| Exhibit_BP28_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP53a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP16_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP45_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP26_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP08_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP07_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP61_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP14_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP72_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_1_en | 2024-05-03 | Not public |
| Exhibit_BP64a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP65_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP69_Amgen_be | 2024-05-03 | Not public |
| Exhibit_BP47a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP20_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP19_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP10_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_3_en | 2024-05-03 | Not public |
| Exhibit_BP34a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP22_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP71_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP30_Amgen_en | 2024-05-03 | Not public |
| Statement_of_defense_and_Counterclaim_for_Revocation_Amgen_May_3_2024_en signed | 2024-05-03 | Not public |
| Exhibit_BP33a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP58_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_2_fr | 2024-05-03 | Not public |
| Exhibit_BP49_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP44_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP27_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP38_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP09_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP24_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP39_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP23_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP63_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP15_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP57_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP69a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP37_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP12_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP66_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_4_en | 2024-05-03 | Not public |
| Exhibit_BP67a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP05_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP13_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP43_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP31_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP29_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP66a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_2_en | 2024-05-03 | Not public |
| Exhibit_BP63a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP18_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_1_fr | 2024-05-03 | Not public |
| Exhibit_BP50a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP33_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP70_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP21_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP55_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP32_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP42_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP35_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP59_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68a-Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP54_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP36_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP73_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP25_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP62_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP40_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP41_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP11_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP17_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP34_Amgen_en | 2024-05-03 | Not public |
| Acknowledgement-of-lodging | 2024-05-03 | Not public |
| Exhibit BP14 | 2024-05-03 | Not public |
| Exhibit BP8 | 2024-05-03 | Not public |
| Exhibit BP73 | 2024-05-03 | Not public |
| Exhibit BP54 | 2024-05-03 | Not public |
| Exhibit BP22 | 2024-05-03 | Not public |
| Exhibit BP5 | 2024-05-03 | Not public |
| Exhibit BP46 | 2024-05-03 | Not public |
| Exhibit BP28 | 2024-05-03 | Not public |
| Exhibit BP6 Part 4 | 2024-05-03 | Not public |
| Exhibit BP69a | 2024-05-03 | Not public |
| Exhibit BP31 | 2024-05-03 | Not public |
| Exhibit BP10 | 2024-05-03 | Not public |
| Exhibit BP26 | 2024-05-03 | Not public |
| Exhibit BP70 | 2024-05-03 | Not public |
| Exhibit BP52a | 2024-05-03 | Not public |
| Exhibit BP33 | 2024-05-03 | Not public |
| Exhibit BP72 | 2024-05-03 | Not public |
| Exhibit BP11 | 2024-05-03 | Not public |
| Exhibit BP42 | 2024-05-03 | Not public |
| Exhibit BP9 | 2024-05-03 | Not public |
| Exhibit BP55 | 2024-05-03 | Not public |
| Exhibit BP7 | 2024-05-03 | Not public |
| Exhibit BP23 | 2024-05-03 | Not public |
| Exhibit BP49a | 2024-05-03 | Not public |
| Exhibit BP12 | 2024-05-03 | Not public |
| Exhibit BP64a | 2024-05-03 | Not public |
| Exhibit BP53a | 2024-05-03 | Not public |
| Exhibit BP18 | 2024-05-03 | Not public |
| Exhibit BP40 | 2024-05-03 | Not public |
| Exhibit BP27 | 2024-05-03 | Not public |
| Exhibit BP49 | 2024-05-03 | Not public |
| Exhibit BP57 | 2024-05-03 | Not public |
| Exhibit BP56 Part 1 | 2024-05-03 | Not public |
| Exhibit BP63a | 2024-05-03 | Not public |
| Exhibit BP30 | 2024-05-03 | Not public |
| Exhibit BP47 | 2024-05-03 | Not public |
| Exhibit BP19 | 2024-05-03 | Not public |
| Exhibit BP47a | 2024-05-03 | Not public |
| Exhibit BP37 | 2024-05-03 | Not public |
| Exhibit BP24 | 2024-05-03 | Not public |
| Exhibit BP43 | 2024-05-03 | Not public |
| Exhibit BP66a | 2024-05-03 | Not public |
| Exhibit BP45 | 2024-05-03 | Not public |
| Exhibit BP21 | 2024-05-03 | Not public |
| Exhibit BP48a | 2024-05-03 | Not public |
| Exhibit BP65 | 2024-05-03 | Not public |
| Exhibit BP41 | 2024-05-03 | Not public |
| Exhibit BP13 | 2024-05-03 | Not public |
| Exhibit BP61 | 2024-05-03 | Not public |
| Exhibit BP16 | 2024-05-03 | Not public |
| Exhibit BP32 | 2024-05-03 | Not public |
| Exhibit BP56 Part 2 | 2024-05-03 | Not public |
| Exhibit BP6 Part 3 | 2024-05-03 | Not public |
| Exhibit BP29 | 2024-05-03 | Not public |
| Exhibit BP66 | 2024-05-03 | Not public |
| Exhibit BP59 | 2024-05-03 | Not public |
| Exhibit BP44 | 2024-05-03 | Not public |
| Exhibit BP48 | 2024-05-03 | Not public |
| Exhibit BP6 Part 1 | 2024-05-03 | Not public |
| Exhibit BP56a | 2024-05-03 | Not public |
| Exhibit BP50 | 2024-05-03 | Not public |
| Exhibit BP69 | 2024-05-03 | Not public |
| Exhibit BP58 | 2024-05-03 | Not public |
| Exhibit BP67a | 2024-05-03 | Not public |
| Exhibit BP71 | 2024-05-03 | Not public |
| Exhibit BP64 | 2024-05-03 | Not public |
| Exhibit BP53 | 2024-05-03 | Not public |
| Exhibit BP20 | 2024-05-03 | Not public |
| Statement of defense | 2024-05-03 | Not public |
| Exhibit BP35 | 2024-05-03 | Not public |
| Exhibit BP39 | 2024-05-03 | Not public |
| Exhibit BP17 | 2024-05-03 | Not public |
| Exhibit BP33a | 2024-05-03 | Not public |
| Exhibit BP38 | 2024-05-03 | Not public |
| Exhibit BP68a | 2024-05-03 | Not public |
| Exhibit BP52 | 2024-05-03 | Not public |
| Exhibit BP60 | 2024-05-03 | Not public |
| Exhibit BP46a | 2024-05-03 | Not public |
| Exhibit BP15 | 2024-05-03 | Not public |
| Exhibit BP51a | 2024-05-03 | Not public |
| Exhibit BP63 | 2024-05-03 | Not public |
| Exhibit BP70a | 2024-05-03 | Not public |
| Exhibit BP50a | 2024-05-03 | Not public |
| Exhibit BP36 | 2024-05-03 | Not public |
| Exhibit BP6 Part 2 | 2024-05-03 | Not public |
| Exhibit BP34 | 2024-05-03 | Not public |
| Exhibit BP68 | 2024-05-03 | Not public |
| Exhibit BP25 | 2024-05-03 | Not public |
| Exhibit BP62 | 2024-05-03 | Not public |
| Exhibit BP51 | 2024-05-03 | Not public |
| Exhibit BP67 | 2024-05-03 | Not public |
| Exhibit BP34a | 2024-05-03 | Not public |
| Exhibit BP60a | 2024-05-03 | Not public |
| Acknowledgement-of-lodging | 2024-05-03 | Not public |
| Exhibit_BP36_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP24_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP65_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP18_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP68_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP63a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP15_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP58_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP09_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP57_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP17_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP55_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP73_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP33a_Amgen_en | 2024-05-03 | Not public |
| Statement_of_defense_and_Counterclaim_for_Revocation_Amgen_May_3_2024_en signed | 2024-05-03 | Not public |
| Exhibit_BP11_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP72_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP34_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_2_fr | 2024-05-03 | Not public |
| Exhibit_BP08_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP34a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP37_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP61_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP35_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP63_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP20_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP12_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP53_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP13_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_3_en | 2024-05-03 | Not public |
| Exhibit_BP07_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68a-Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP66_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP10_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_4_en | 2024-05-03 | Not public |
| Exhibit_BP66a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP38_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP21_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP16_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP19_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP28_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP59_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_2_en | 2024-05-03 | Not public |
| Exhibit_BP31_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP27_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP54_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP45_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP30_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP42_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP62_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP25_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_1_en | 2024-05-03 | Not public |
| Exhibit_BP23_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP44_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP05_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP26_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP39_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP33_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP56a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP51_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP69_Amgen_be | 2024-05-03 | Not public |
| Exhibit_BP69a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP40_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP50_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP32_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP14_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP29_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP71_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP41_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP43_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_1_fr | 2024-05-03 | Not public |
| Exhibit_BP22_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48_Amgen_fr | 2024-05-03 | Not public |
| Acknowledgement-of-lodging | 2024-05-03 | Not public |
| Exhibit_BP33_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_2_en | 2024-05-03 | Not public |
| Exhibit_BP47a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68a-Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_1_fr | 2024-05-03 | Not public |
| Exhibit_BP49a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP23_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP38_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_3_en | 2024-05-03 | Not public |
| Exhibit_BP57_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP13_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP73_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP55_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP19_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP72_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP05_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_1_en | 2024-05-03 | Not public |
| Exhibit_BP08_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP30_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP62_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP34a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP64_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP09_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP27_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP29_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP59_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP28_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP25_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP22_Amgen_en | 2024-05-03 | Not public |
| Statement_of_defense_and_Counterclaim_for_Revocation_Amgen_May_3_2024_en signed | 2024-05-03 | Not public |
| Exhibit_BP48a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP26_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_2_fr | 2024-05-03 | Not public |
| Exhibit_BP16_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP63a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP21_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP31_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP69a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP18_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_4_en | 2024-05-03 | Not public |
| Exhibit_BP11_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP68_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP71_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP41_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP45_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP14_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP36_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP69_Amgen_be | 2024-05-03 | Not public |
| Exhibit_BP64a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP32_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP66a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP15_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP39_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP65_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP12_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP24_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP37_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP48_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP17_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP61_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP54_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP33a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP35_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP07_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP66_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP34_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP67a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP43_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP10_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP58_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP42_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP44_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP40_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP63_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP52a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP20_Amgen_en | 2024-05-03 | Not public |
| Acknowledgement-of-lodging | 2024-05-03 | Not public |
| Exhibit_BP24_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP67_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP48_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP13_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP10_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP22_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP15_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP09_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP70a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP14_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP21_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP42_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP57_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49_Amgen_fr | 2024-05-03 | Not public |
| Exhibit_BP59_Amgen_en | 2024-05-03 | Not public |
| Statement of defense | 2024-05-03 | Not public |
| Exhibit_BP64_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP07_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP54_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP25_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP62_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP35_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP27_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP18_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_2_fr | 2024-05-03 | Not public |
| Exhibit_BP43_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP17_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP32_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP41_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP73_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_4_en | 2024-05-03 | Not public |
| Exhibit_BP70_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP36_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP58_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP05_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP08_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP51_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP46_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP64a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_3_en | 2024-05-03 | Not public |
| Exhibit_BP40_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP46a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP66_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP48a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP56_Amgen_Part_1_fr | 2024-05-03 | Not public |
| Exhibit_BP37_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP26_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP29_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_2_en | 2024-05-03 | Not public |
| Exhibit_BP69a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP71_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP28_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP52a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP63_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP33_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP67a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP19_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP68_Amgen_it | 2024-05-03 | Not public |
| Exhibit_BP61_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP34_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP68a-Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP63a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP69_Amgen_be | 2024-05-03 | Not public |
| Exhibit_BP23_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP47_Amgen_nl | 2024-05-03 | Not public |
| Exhibit_BP06_Amgen_Part_1_en | 2024-05-03 | Not public |
| Exhibit_BP65_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP33a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP66a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP45_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP12_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP72_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP55_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP44_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP50a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP20_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP11_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP49a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP16_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP34a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP60a_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP39_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP38_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP53_Amgen_de | 2024-05-03 | Not public |
| Exhibit_BP30_Amgen_en | 2024-05-03 | Not public |
| Exhibit_BP31_Amgen_en | 2024-05-03 | Not public |
| commentPreliminaryObjection | 2024-03-18 | Not public |
| Response to Preliminary Objection | 2024-03-18 | Not public |
| Federal Patent Court, Summons and Preliminary Opinion in accordance with Sec. 83 German Patent Act | 2024-03-18 | Not public |
| Federal Patent Court, Summons and Preliminary Opinion in accordance with Sec. 83 German Patent Act | 2024-03-18 | Not public |
| preliminaryObjection | 2024-03-04 | Not public |
| Exhibit BP03 | 2024-03-04 | Not public |
| Preliminary Objection | 2024-03-04 | Not public |
| Exhibit BP04 | 2024-03-04 | Not public |
| Exhibit BP02a | 2024-03-04 | Not public |
| Exhibit BP02 | 2024-03-04 | Not public |
| Exhibit BP01 | 2024-03-04 | Not public |
| Exhibit BP01a | 2024-03-04 | Not public |
| Exhibit BP03a | 2024-03-04 | Not public |
| Exhibit BP04a | 2024-03-04 | Not public |
| epoUploadDocumentsWorkflow | 2024-02-09 | Not public |
| Document from EPO | 2024-02-09 | Not public |
| Acknowledgement of access to case | 2024-02-05 | Not public |
| Notification Of Service | 2024-02-05 | Not public |
| Acknowledgement of access to case | 2024-02-05 | Not public |
| Notification Of Service | 2024-02-05 | Not public |
| Acknowledgement of access to case | 2024-02-05 | Not public |
| Notification Of Service | 2024-02-05 | Not public |
| Acknowledgement of access to case | 2024-02-05 | Not public |
| Notification Of Service | 2024-02-05 | Not public |
| Acknowledgement of access to case | 2024-02-05 | Not public |
| Notification Of Service | 2024-02-05 | Not public |
| Acknowledgement of access to case | 2024-02-05 | Not public |
| Notification Of Service | 2024-02-05 | Not public |
| Acknowledgement of access to case | 2024-02-05 | Not public |
| Notification Of Service | 2024-02-05 | Not public |
| Panel-Appointment | 2024-01-25 | Not public |
| EPO-Request-for-case-pending | 2024-01-25 | Not public |
| Receipt | 2024-01-25 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-01-25 | Not public |
| Acknowledgement-of-lodging | 2024-01-10 | Not public |
| HE 27 - EMA’s Guideline on Summary of Product Characteristics (SmPC) of September 2009 | 2024-01-10 | Not public |
| HE 2 - Printouts from patent register [bundle] | 2024-01-10 | Not public |
| HE 25 - Higher Regional Court of Dusseldorf, GRUR 2019, 279 – Fulvestrant | 2024-01-10 | Not public |
| HE 29 - CMDh Questions & Answers on Usage Patents, CMDh/279/2012, Rev. 1, May 2019 | 2024-01-10 | Not public |
| HE 3 - EP 2 756 004 B1 | 2024-01-10 | Not public |
| HE 20 - F. Kronenberg et al., European Heart Journal (2022) 43, 3925–3946 | 2024-01-10 | Not public |
| HE 38 - Confirmatory License Agreement | 2024-01-10 | Not public |
| HE 11 - Grounds for Defence to Nullity Action dated 15 November 2023 | 2024-01-10 | Not public |
| HE 4 - Notice on the outcome of the opposition on EP’004 of 8/9 June 2022 | 2024-01-10 | Not public |
| HE 9 - Amgen’s submissions on infringement of EP’004 before the RC Dusseldorf (bundle) | 2024-01-10 | Not public |
| HE 6 - Board of Appeal (T1927/22-3.3.04), Preliminary opinion on EP’004 of 6 October 2023 | 2024-01-10 | Not public |
| HE 5 - Opposition Division, Grounds for the decision on EP’004 of 16 August 2022 | 2024-01-10 | Not public |
| HE 26 - Hoge Raad, Judgement of 3 November 2017, 15/04934, ECLI:NL:HR:2017:2807 | 2024-01-10 | Not public |
| HE 35 - Press release of Defendant 1) of 21. July 2015 | 2024-01-10 | Not public |
| HE 12 - Nordestgaard et al, European Heart Journal, 31, 2844-2853, 2010 | 2024-01-10 | Not public |
| HE 36 - Press release of Defendant 1) of 21. February 2017 | 2024-01-10 | Not public |
| HE 30 - EMA, CHMP, Assessment report Repatha®, EMA/CHMP/222019/2015 (excerpt) | 2024-01-10 | Not public |
| HE 31 - EMA, CHMP, CHMP day 120 list of questions, Evolocumab Amgen Europe B.V., EMA/CHMP/33068/2015 (excerpt) | 2024-01-10 | Not public |
| HE 41 - Appointment Alban De La Sablière | 2024-01-10 | Not public |
| HE 26a - English translation (EN) | 2024-01-10 | Not public |
| HE 17 - Feature Analysis Patent in Suit | 2024-01-10 | Not public |
| HE 19 - Wilson et al., Journal of Clinical Lipidology (2019) 13, 374–392 | 2024-01-10 | Not public |
| HE 28 - Case T452/14, Laboratoires CTRS v European Commission, ECLI:EU:T:2015:373 | 2024-01-10 | Not public |
| HE 8 - Claimants’ submissions on infringement of EP’004 before the RC Dusseldorf (bundle) | 2024-01-10 | Not public |
| HE 10 - Amgen’s Nullity Action on EP’004 dated 3 August 2023 filed before the Federal Patent Court (3 Ni 21/23) | 2024-01-10 | Not public |
| HE 34 - EP 2 215 124 B9 (excerpt) | 2024-01-10 | Not public |
| HE 15 - Bennet et al, Arch Intern Med, Vol. 168, No. 6, 2008; | 2024-01-10 | Not public |
| HE 22 - Website https://fachkreise.amgen.de/Produkte/Repatha/index.html | 2024-01-10 | Not public |
| 240110 Statement of Claim_sig | 2024-01-10 | Not public |
| HE 13 - Horton et al., 2009 | 2024-01-10 | Not public |
| HE 40 - Power of Attorney John C. Conway (French) | 2024-01-10 | Not public |
| HE 21 - Expert declaration Prof. Klaus G. Parhofer | 2024-01-10 | Not public |
| HE 7 - Board of Appeal (T1927/22-3.3.04), Minutes of the hearing on 6 December 2023 | 2024-01-10 | Not public |
| HE 40a - Translation HE 40 (EN) | 2024-01-10 | Not public |
| HE 16 - JAMA. 2009;302(4):412-423. doi:10.1001/jama.2009.1063 (including online supplement) | 2024-01-10 | Not public |
| HE 14 - Expert Report I by Emanuele Di Angelantonio from the European opposition proceedings (D64) | 2024-01-10 | Not public |
| HE 18 - V Bermudez et. al, American Journal of Therapeutics 17, 263-273 (2 | 2024-01-10 | Not public |
| HE 23 - SmPC of Repatha® | 2024-01-10 | Not public |
| HE 33 - Amgen Inc., Annual Report (10-K Filing) for fiscal year ended December 31, 2020 (excerpt) | 2024-01-10 | Not public |
| HE 37 - Lauer-Taxe excerpt | 2024-01-10 | Not public |
| HE 1 - EP 3 536 712 B1 | 2024-01-10 | Not public |
| HE 39 - Appointment Larry Coury – Secretary Certificate | 2024-01-10 | Not public |
| HE 32 - Parhofer KG et al, Drugs - Real World Outcomes 2019; 6: 115-123 | 2024-01-10 | Not public |
| HE 24 - Fachinformationen Repatha® | 2024-01-10 | Not public |
| HE 25a - Machine translation (EN) | 2024-01-10 | Not public |
| Proof of payment | 2024-01-10 | Not public |